Furthermore, marginally significant differences were noted in the incidence of grade 3 toxicities between the patients with a loss of lean body mass <5% and a loss of lean body mass ≥5% (18.9% vs. 42.9%, P=0.050).
← all excerpts
The postoperative lean body mass loss at one month leads to a poor survival in patients with locally advanced gastric cancer.
1
—
—